Aperio Group’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | $1.07M | Buy |
79,106
+9,978
| +14% | +$135K | ﹤0.01% | 1562 |
|
2020
Q3 | $814K | Buy |
69,128
+55,684
| +414% | +$656K | ﹤0.01% | 1553 |
|
2020
Q2 | $198K | Sell |
13,444
-221
| -2% | -$3.26K | ﹤0.01% | 2180 |
|
2020
Q1 | $185K | Sell |
13,665
-2,770
| -17% | -$37.5K | ﹤0.01% | 2112 |
|
2019
Q4 | $398K | Buy |
16,435
+3,166
| +24% | +$76.7K | ﹤0.01% | 1928 |
|
2019
Q3 | $255K | Buy |
13,269
+5,496
| +71% | +$106K | ﹤0.01% | 2087 |
|
2019
Q2 | $230K | Sell |
7,773
-1,257
| -14% | -$37.2K | ﹤0.01% | 2129 |
|
2019
Q1 | $429K | Buy |
9,030
+2,184
| +32% | +$104K | ﹤0.01% | 1840 |
|
2018
Q4 | $247K | Buy |
6,846
+1,591
| +30% | +$57.4K | ﹤0.01% | 2038 |
|
2018
Q3 | $323K | Sell |
5,255
-18
| -0.3% | -$1.11K | ﹤0.01% | 1974 |
|
2018
Q2 | $356K | Sell |
5,273
-369
| -7% | -$24.9K | ﹤0.01% | 1924 |
|
2018
Q1 | $306K | Sell |
5,642
-79
| -1% | -$4.29K | ﹤0.01% | 1948 |
|
2017
Q4 | $342K | Buy |
5,721
+504
| +10% | +$30.1K | ﹤0.01% | 1880 |
|
2017
Q3 | $253K | Buy |
5,217
+303
| +6% | +$14.7K | ﹤0.01% | 2020 |
|
2017
Q2 | $259K | Buy |
4,914
+219
| +5% | +$11.5K | ﹤0.01% | 1969 |
|
2017
Q1 | $213K | Buy |
+4,695
| New | +$213K | ﹤0.01% | 2010 |
|